Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism

Fig. 2

ALDH1A1 and ALDH1A3 regulate TGFB1 gene expression through RA-dependent mechanism. A Relative mRNA expression of TGFB1 gene in LNCaP, C4-2B and PC3 cells upon knockdown of ALDH1A1 or ALDH1A3 expression. Cells transfected with scrambled siRNA (siScr) were used as a control. n ≥ 3; Error bars = SD; *p < 0.05; ***p < 0.001. B Distribution of log2 fold change values (relative to siScr control) for TGFB1 up or down genes. The gene sets for the TGFB1 responsive genes were described previously [59]. Values are sorted from high to low in each column independently; therefore, the order of gene names is not the same. Significance of enrichment for up- or down-regulated genes evaluated by Wilcoxon signed rank test; *p < 0.05; **p < 0.01; ***p < 0.001; n.s. – non-significant. C Correlation of ALDH1A1 and ALDH1A3 expression with TGFB1 mRNA levels in the PCa gene expression datasets TCGA PRAD (n = 493), MSKCC primary (n = 131), Broad/Cornell (n = 31), DKFZ (n = 118), and SMMU (n = 65) and non-cancerous tissues (MSKCC cohort, n = 29); *p < 0.05; n.s.- non significant. D Correlation of RXRA and RARA expression with TGFB1 mRNA levels in the PCa gene expression datasets TCGA PRAD (n = 493), MSKCC primary (n = 131), Broad/Cornell (n = 31), DKFZ (n = 118), and SMMU (n = 65) and non-cancerous tissues (MSKCC cohort, n = 29); *p < 0.05; n.s.- non significant. E LNCaP, C4-2B or PC3 cells were treated with various concentrations of ATRA (10 μM, 25 μM, and 50 μM) or DMSO as a control for 48 h. Relative mRNA expression of ALDH1A1, ALDH1A3 and TGFB1 was measured by qPCR analysis. n ≥ 3; Error bars = SD; *p < 0.05; **p < 0.01; ***p < 0.001. F 22Rv1 cells were transfected with pGL3-TGFB1 luciferase reporter plasmid [44] and treated with various concentrations of ATRA or 9CisRA (10 μM, 25 μM, and 50 μM) and DMSO as a control. Luciferase activity was measured 48 h after the treatment started. n ≥ 3; Error bars = SD; *p < 0.05. G qPCR analysis of TGFB1 expression in LNCaP cells upon transient RARA overexpression, treatment with ATRA or 9CisRA for 48 h or both. Cells transfected with empty plasmid were used as control. n ≥ 4; Error bars = SD; **p < 0.01; ***p < 0.001; ****p < 0.0001; n.s.—non significant

Back to article page